The Effect of Rubus idaeus Polyphenols Extract in Induced Endometriosis in Rats

Elena-Mihaela Jianu,Raluca Maria Pop,Luciana Mădălina Gherman,Floricuța Ranga,Antonia-Mihaela Levai,Vasile Rus,Sorana D. Bolboacă,Roxana-Adelina Ștefan,Mădălin Mihai Onofrei,Ionel-Daniel Nati,Ioana Alexandra Stoia,Paul-Andrei Ștefan,Carina Mihu,Carmen Mihaela Mihu

DOI: https://doi.org/10.3390/molecules29040778

IF: 4.6

2024-02-08

Molecules

Abstract:Endometriosis is a common gynecological condition with a complex physio-pathological background. This study aimed to assess the role of Rubus idaeus leaf extract (RiDE) as a potential therapeutic agent in reducing the size of the endometriotic lesions and modulate the plasma expression of MMP-2, MMP-9, and TGF-β1. The endometriotic lesions were induced in a rat model by the autologous transplant of endometrium. Thirty-six female rats, Wistar breed, with induced endometriosis, were divided into four groups and underwent treatment for 28 days. The CTRL group received 0.5 mL/day of the vehicle; the DG group received 1 mg/kg b.w./day dienogest; the RiDG group received 0.25 mL/kg b.w./day RiDE and the D+RiDG group received 1 mg/kg b.w./day dienogest and 0.25 mL/kg b.w./day RiDE, respectively. Rats' weight, endometriotic lesion diameter and grade, and plasma levels of MMP-2, MMP-9, and TGF-β1 were assessed before and after treatment. The administration of RiDE in association with dienogest vs. dienogest determined a lower weight gain and a reduction in diameter of the endometriotic lesions. RiDE administration restored MMP2 and MMP9 plasma levels to initial conditions. Rubus idaeus extract may help in reducing dienogest-associated weight gain, lower the size of endometriotic lesions, and have anti-inflammatory effects through MMP2 and MMP9 reduction.

chemistry, multidisciplinary,biochemistry & molecular biology

What problem does this paper attempt to address?

The paper aims to investigate the effects of raspberry (Rubus idaeus) leaf extract (RiDE) in a rat-induced endometriosis model, specifically evaluating its potential as a therapeutic agent to reduce the size of endometriotic lesions and regulate the plasma expression levels of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), and transforming growth factor-β1 (TGF-β1).

Specifically, the study was conducted through the following aspects:
1. **Induction of Endometriosis**: Endometriosis was successfully induced in rats by autotransplantation of the endometrium.
2. **Treatment of Different Groups**: The rats with induced endometriosis were divided into four groups for 28 days of treatment:
- Control group (CTRL): Given 0.5 mL of the carrier daily;
- Dienogest group (DG): Given 1 mg/kg body weight of dienogest daily;
- Raspberry leaf extract group (RiDG): Given 0.25 mL/kg body weight of RiDE daily;
- Dienogest plus raspberry leaf extract group (D+RiDG): Given 1 mg/kg body weight of dienogest and 0.25 mL/kg body weight of RiDE daily.
3. **Efficacy Evaluation**: The body weight of the rats, the diameter and grading of endometriotic lesions, and the plasma levels of MMP-2, MMP-9, and TGF-β1 were measured.

The results showed that, compared to the use of dienogest alone, the combined use of RiDE significantly reduced the weight gain of the rats and the diameter of the endometriotic lesions. Additionally, the use of RiDE restored the plasma levels of MMP-2 and MMP-9 to their initial states, demonstrating certain anti-inflammatory effects. However, RiDE did not affect the plasma levels of TGF-β1. Overall, raspberry leaf extract may help mitigate the weight gain caused by dienogest and reduce the size of endometriotic lesions by exerting anti-inflammatory effects through the reduction of MMP-2 and MMP-9 levels.